{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:36Z","timestamp":1787032896751,"version":"build-2736575974"},"reference-count":39,"publisher":"XMLink","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["ecevr.org"],"crossmark-restriction":false},"short-container-title":["Clin Exp Vaccine Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.7774\/cevr.2022.11.2.193","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:41:28Z","timestamp":1655260888000},"page":"193","update-policy":"https:\/\/doi.org\/10.7774\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media"],"prefix":"10.7774","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-7593","authenticated-orcid":false,"given":"Emmanuel","family":"Lamptey","sequence":"first","affiliation":[{"name":"Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Oyo, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-701X","authenticated-orcid":false,"given":"Ephraim Kumi","family":"Senkyire","sequence":"additional","affiliation":[{"name":"Ga-West Municipal Hospital, Ghana Health Service, Accra, Ghana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-4415","authenticated-orcid":false,"given":"Serwaa","family":"Dorcas","sequence":"additional","affiliation":[{"name":"Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Oyo, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-4411","authenticated-orcid":false,"given":"Dooshima Aki","family":"Benita","sequence":"additional","affiliation":[{"name":"Department of Psychology, Benue State University, Makurdi, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0737-5126","authenticated-orcid":false,"given":"Evans Osei","family":"Boakye","sequence":"additional","affiliation":[{"name":"Department of Social Work, University of Ghana, Accra, Ghana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-306X","authenticated-orcid":false,"given":"Theckla","family":"Ikome","sequence":"additional","affiliation":[{"name":"Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Oyo, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-8620","authenticated-orcid":false,"given":"Alex","family":"Asamoah","sequence":"additional","affiliation":[{"name":"Shai Osudoku District Hospital, Ghana Health Service, Accra, Ghana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","reference":[{"key":"10.7774\/cevr.2022.11.2.193_ref1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","volume":"20","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.7774\/cevr.2022.11.2.193_ref2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"key":"10.7774\/cevr.2022.11.2.193_ref3","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape [Internet]. Geneva. World Health Organization. 2021. cited 2021 Mar 7. Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"10.7774\/cevr.2022.11.2.193_ref4","unstructured":"Centers for Disease Control and Prevention. About COVID-19 vaccines [Internet]. Atlanta (GA). Centers for Disease Control and Prevention. 2021. cited 2021 May 27. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html#about-vaccines"},{"key":"10.7774\/cevr.2022.11.2.193_ref5","doi-asserted-by":"crossref","first-page":"0056","DOI":"10.1038\/s41562-017-0056","volume":"1","author":"Betsch","year":"2017","journal-title":"Nat Hum Behav"},{"key":"10.7774\/cevr.2022.11.2.193_ref6","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3201\/eid2607.200282","volume":"26","author":"Sanche","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.7774\/cevr.2022.11.2.193_ref7","unstructured":"COVID-19 vaccine tracker [Internet]. Rockville (MD). Regulatory Affairs Professionals Society. [date unknown]. cited 2021 Jul 9. Available from: https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker"},{"key":"10.7774\/cevr.2022.11.2.193_ref8","unstructured":"World Health Organization. 172 Countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility [Internet]. Geneva. World Health Organization. 2020. cited 2021 Jul 9. Available from: https:\/\/www.who.int\/news\/item\/24-08-2020-172-countries-and-multiple-candidate-vaccines-engaged-in-covid-19-vaccine-global-access-facility"},{"key":"10.7774\/cevr.2022.11.2.193_ref9","unstructured":"Centers for Disease Control and Prevention. Benefits of getting vaccinated [Internet]. Atlanta (GA). Centers for Disease Control and Prevention. cited 2021 Jul 9. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/vaccine-benefits.html"},{"key":"10.7774\/cevr.2022.11.2.193_ref10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.dsx.2021.02.031","volume":"15","author":"Praveen","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.7774\/cevr.2022.11.2.193_ref11","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1080\/10410236.2020.1838096","volume":"35","author":"Chou","year":"2020","journal-title":"Health Commun"},{"key":"10.7774\/cevr.2022.11.2.193_ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.11604\/pamj.2021.38.3.27401","volume":"38","author":"Afolabi","year":"2021","journal-title":"Pan Afr Med J"},{"key":"10.7774\/cevr.2022.11.2.193_ref13","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0040073","volume":"4","author":"Jegede","year":"2007","journal-title":"PLoS Med"},{"key":"10.7774\/cevr.2022.11.2.193_ref14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1475-2875-12-156","volume":"12","author":"Febir","year":"2013","journal-title":"Malar J"},{"key":"10.7774\/cevr.2022.11.2.193_ref15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.28991\/SciMedJ-2020-0203-1","volume":"2","author":"Okunlola","year":"2020","journal-title":"SciMed J"},{"key":"10.7774\/cevr.2022.11.2.193_ref16","unstructured":"Ipsos. US and UK are optimistic indicators for COVID-19 vaccination uptake [Internet]. Paris. Ipsos. 2020. cited 2021 Jul 9. Available from: https:\/\/www.ipsos.com\/en\/global-attitudes-covid-19-vaccine-december-2020"},{"key":"10.7774\/cevr.2022.11.2.193_ref17","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1016\/j.vaccine.2020.09.041","volume":"38","author":"Detoc","year":"2020","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2022.11.2.193_ref18","unstructured":"COVID-19 vaccinations: African nations miss WHO target. BBS News [Internet]. 2021. cited 2021 Jul 9. Available from: https:\/\/www.bbc.com\/news\/56100076"},{"key":"10.7774\/cevr.2022.11.2.193_ref19","unstructured":"Africa CDC. COVID 19 vaccine perceptions: a 15 country study [Internet]. Addis Ababa. African Union. 2021. cited 2021 Jul 9. Available from: https:\/\/africacdc.org\/download\/covid-19-vaccine-perceptions-a-15-country-study\/"},{"key":"10.7774\/cevr.2022.11.2.193_ref20","doi-asserted-by":"crossref","first-page":"e0236918","DOI":"10.1371\/journal.pone.0236918","volume":"15","author":"Hager","year":"2020","journal-title":"PLoS One"},{"key":"10.7774\/cevr.2022.11.2.193_ref21","unstructured":"COVID-19 vaccines: myth versus fact [Internet]. Baltimore (MD). Johns Hopkins Medicine. 2021. cited 2021 Jul 9. Available from: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/coronavirus\/covid-19-vaccines-myth-versus-fact"},{"key":"10.7774\/cevr.2022.11.2.193_ref22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/14760584.2020.1825945","volume":"19","author":"Verger","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.7774\/cevr.2022.11.2.193_ref23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/21645515.2019.1695458","volume":"16","author":"Shen","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.7774\/cevr.2022.11.2.193_ref24","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2011.11.112","volume":"30","author":"Kata","year":"2012","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2022.11.2.193_ref25","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/j.vaccine.2012.02.025","volume":"30","author":"Betsch","year":"2012","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2022.11.2.193_ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajog.2021.03.023","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.7774\/cevr.2022.11.2.193_ref27","unstructured":"Centers for Disease Control and Prevention. COVID-19 Vaccines While Pregnant or Breastfeeding [Internet]. Atlanta (GA). Centers for Disease Control and Prevention. 2021. cited 2021 Jul 9. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html"},{"key":"10.7774\/cevr.2022.11.2.193_ref28","unstructured":"American College of Obstetricians and Gynecologists\u2019 Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group. COVID-19 vaccination considerations for obstetric\u2013gynecologic care [Internet]. Washington (DC). American College of Obstetricians and Gynecologists. 2021. cited 2021 Jul 8. Available from: https:\/\/www.acog.org\/en\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/covid-19-vaccination-considerations-for-obstetric-gynecologic-care"},{"key":"10.7774\/cevr.2022.11.2.193_ref29","unstructured":"Society for Maternal-Fetal Medicine. COVID-19 vaccines and pregnancy [Internet]. Washington (DC). Society for Maternal-Fetal Medicine. cited 2021 Jul 8. Available from: https:\/\/www.highriskpregnancyinfo.org\/covid-19-pregnancy"},{"key":"10.7774\/cevr.2022.11.2.193_ref30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-020-0188-3","volume":"5","author":"Kim","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.7774\/cevr.2022.11.2.193_ref31","unstructured":"National Academies of Sciences, Engineering, and Medicine. Framework for equitable allocation of COVID-19 vaccine [Internet]. Washington (DC). National Academies Press. 2020. cited 2021 Jul 8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562672\/"},{"key":"10.7774\/cevr.2022.11.2.193_ref32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol Ther"},{"key":"10.7774\/cevr.2022.11.2.193_ref33","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.7774\/cevr.2022.11.2.193_ref34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.7774\/cevr.2022.11.2.193_ref35","unstructured":"COVID-19 vaccines: development, evaluation, approval and monitoring [Internet]. Amsterdam. European Medicines Agency. 2020. cited 2021 Jul 8. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-development-evaluation-approval-monitoring"},{"key":"10.7774\/cevr.2022.11.2.193_ref36","unstructured":"What you need to know about COVID-19 vaccine approvals in Nigeria and South Africa [Internet]. Washington (DC). GAVI. 2020. cited 2021 Jul 9. Available from: https:\/\/www.gavi.org\/vaccineswork\/what-you-need-know-about-covid-19-vaccine-approvals-nigeria-and-south-africa"},{"key":"10.7774\/cevr.2022.11.2.193_ref37","unstructured":"Ghana Food and Drugs Authority. Safetywatch update no.1: COVID-19 vaccine safety monitoring update [Internet]. Accra. Ghana Food and Drugs Authority. 2021. cited 2021 Jul 9. Available from: http:\/\/fdaghana.gov.gh\/news-media.php?page=78"},{"key":"10.7774\/cevr.2022.11.2.193_ref38","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/JMDH.S276771","volume":"13","author":"Al-Mohaithef","year":"2020","journal-title":"J Multidiscip Healthc"},{"key":"10.7774\/cevr.2022.11.2.193_ref39","unstructured":"World Health Organization. COVAX Joint Statement: call to action to equip COVAX to deliver 2 billion doses in 2021 [Internet]. Geneva. World Health Organization. 2021. cited 2021 Jul 9. Available from: https:\/\/www.who.int\/news\/item\/27-05-2021-covax-joint-statement-call-to-action-to-equip-covax-to-deliver-2-billion-doses-in-2021"}],"container-title":["Clinical and Experimental Vaccine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ecevr.org\/pdf\/10.7774\/cevr.2022.11.2.193","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2022.11.2.193","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2022.11.2.193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:45:45Z","timestamp":1655261145000},"score":1,"resource":{"primary":{"URL":"https:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2022.11.2.193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7774\/cevr.2022.11.2.193","relation":{},"ISSN":["2287-3651","2287-366X"],"issn-type":[{"value":"2287-3651","type":"print"},{"value":"2287-366X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2021-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-11","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 Korean Vaccine Society.","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}